Amanote Research
Register
Sign In
Adult Atypical Sporadic Burkitt Lymphoma Successfully Treated With Bendamustine and Rituximab
Lymphoma and Chronic Lymphocytic Leukemias
doi 10.4137/lcll.s9978
Full Text
Open PDF
Abstract
Available in
full text
Date
January 1, 2013
Authors
Unknown
Publisher
Portico
Related search
Maintenance Rituximab or Observation After Frontline Treatment With Bendamustine-Rituximab for Follicular Lymphoma
British Journal of Haematology
Hematology
Tumefactive Fibroinflammatory Lesion Successfully Treated With Rituximab
Intractable and Rare Diseases Research
Medicine
Excellent Real-World Outcomes of Adults With Burkitt Lymphoma Treated With CODOX-M/IVAC Plus or Minus Rituximab
British Journal of Haematology
Hematology
Chronic Hepatitis E in Patients With Indolent Lymphoma After Treatment With Rituximab and Bendamustine
Hepatology
Medicine
Hepatology
Cutaneous Tumor of the Arm Revealing a Sporadic Burkitt Lymphoma
Journal of the American Geriatrics Society
Gerontology
Geriatrics
Severe Refractory Paraneoplastic Mucous Membrane Pemphigoid Successfully Treated With Rituximab
Frontiers in Medicine
Medicine
Bendamustine Combined With Rituximab for Patients With Relapsed or Refractory Diffuse Large B Cell Lymphoma
Annals of Hematology
Medicine
Hematology
Atypical Cogan's Syndrome Successfully Treated With Corticosteroids and Pulse Cyclophosphamide Therapy
Fukushima Journal of Medical Sciences
Medicine
Rituximab, Bendamustine and Cytarabine (R-Bac) in Patients With Relapsed-Refractory Aggressive B-Cell Lymphoma
American Journal of Hematology
Hematology
